XML 174 R47.htm IDEA: XBRL DOCUMENT v3.25.3
License and Collaboration Agreements (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jan. 31, 2023
Dec. 31, 2022
Jan. 31, 2019
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
License and Collaboration Agreements [Line Items]                    
Agreement initial term     5 years              
Milestone payments           $ 11,100   $ 11,100    
Original celltrion agreement           87.50%   87.50%    
Amended celltrion agreement           250.00%   250.00%    
Percentage of reimbursement               60.00%    
Revenue recognized            
Accounts receivable                 $ 53  
Research and development services                   $ 64
Performance obligation               $ 0 64  
Intellectual Property [Member]                    
License and Collaboration Agreements [Line Items]                    
Research and development services               1,936    
First Milestone [Member]                    
License and Collaboration Agreements [Line Items]                    
Milestone payments $ 2,000 $ 2,000           2,000 2,000 $ 2,000
ABP-100 Collaboration and License Agreement [Member]                    
License and Collaboration Agreements [Line Items]                    
Royalty payment                  
Research and Development Expense [Member]                    
License and Collaboration Agreements [Line Items]                    
Milestone payments           70,000   70,000    
Royalties amount       $ 6 $ 6 19 $ 19 25 25  
NJCTTQ Collaboration Agreement [Member]                    
License and Collaboration Agreements [Line Items]                    
Milestone payments           405,000        
Aggregate non-refundable payments           5,000   5,000    
Royalties amount           5,000   5,000    
ABP-201 Collaboration and License Agreement [Member]                    
License and Collaboration Agreements [Line Items]                    
Milestone payments           56,500   56,500    
Celltrion Collaboration and License Agreement [Member]                    
License and Collaboration Agreements [Line Items]                    
Milestone payments           1,750,000   1,750,000    
Original celltrion agreement           $ 10,000   $ 10,000    
Percentage of reimbursement           50.00%   50.00%    
Celltrion Collaboration and License Agreement [Member] | First Milestone [Member]                    
License and Collaboration Agreements [Line Items]                    
Milestone payments                  
Celltrion Collaboration and License Agreement [Member] | Research and Development Expense [Member]                    
License and Collaboration Agreements [Line Items]                    
Original celltrion agreement           6,000   $ 6,000    
ABP-100 Collaboration and License Agreement [Member]                    
License and Collaboration Agreements [Line Items]                    
Guaranteed annual minimum royalties               30    
Royalty payment                 23  
ABI [Member]                    
License and Collaboration Agreements [Line Items]                    
Milestone payments           485,000   485,000    
Minimum [Member]                    
License and Collaboration Agreements [Line Items]                    
Royalties amount           $ 20   $ 20    
Amended celltrion agreement           25.00%   25.00%    
Minimum [Member] | Research and Development Expense [Member]                    
License and Collaboration Agreements [Line Items]                    
Royalties amount               $ 0 $ 20  
Maximum [Member]                    
License and Collaboration Agreements [Line Items]                    
Royalties amount           $ 30   $ 30    
Amended celltrion agreement           50.00%   50.00%    
Maximum [Member] | Research and Development Expense [Member]                    
License and Collaboration Agreements [Line Items]                    
Royalties amount               $ 498,000    
Maximum [Member] | NJCTTQ Collaboration Agreement [Member]                    
License and Collaboration Agreements [Line Items]                    
Aggregate non-refundable payments               $ 405,000